JOEL S MARCUS Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JOEL S MARCUS.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JOEL S MARCUS. JOEL S MARCUS is Chief Executive Officer in ALEXANDRIA REAL ESTATE EQUITIES INC ($ARE) and Executive Chairman in ALEXANDRIA REAL ESTATE EQUITIES INC ($ARE) and Director in Intra-Cellular Therapies, Inc. ($ITCI) and Director in Atara Biotherapeutics, Inc. ($ATRA) and Director in Applied Therapeutics Inc. ($APLT) and Director in Frequency Therapeutics, Inc. ($FREQ) and Director in MeiraGTx Holdings plc ($MGTX).
Latest Insider Trading Transactions of JOEL S MARCUS
Sentiment: All, ARE, APLT, ATRA, FREQ, ITCI, MGTX
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
Aug 22 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Executive Chairman | Sell | S | 128.38 | 10,000 | 1,283,800 | 572,255 | 582.3 K to 572.3 K (-1.72 %) |
Aug 06 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Executive Chairman | Sell | S | 126.87 | 29,500 | 3,742,665 | 582,255 | 611.8 K to 582.3 K (-4.82 %) |
Jun 20 2018 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 0.00 | 14,189 | 0 | 14,189 | |
Jun 20 2018 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 0.00 | 14,189 | 0 | 14,189 | |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Option Exercise | A | 45.65 | 5,000 | 228,250 | 5,000 | |
Jun 18 2018 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 1,500 | 0 | 8,500 | 7 K to 8.5 K (+21.43 %) |
May 09 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Executive Chairman | Sell | S | 128.52 | 15,000 | 1,927,800 | 624,755 | 639.8 K to 624.8 K (-2.34 %) |
May 09 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Executive Chairman | Sell | S | 128.52 | 15,000 | 1,927,800 | 624,755 | 639.8 K to 624.8 K (-2.34 %) |
May 09 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Executive Chairman | Sell | S | 128.56 | 5,000 | 642,800 | 639,755 | 644.8 K to 639.8 K (-0.78 %) |
May 09 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Executive Chairman | Sell | S | 128.56 | 5,000 | 642,800 | 639,755 | 644.8 K to 639.8 K (-0.78 %) |
May 07 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Executive Chairman | Sell | S | 127.84 | 12,000 | 1,534,080 | 644,755 | 656.8 K to 644.8 K (-1.83 %) |
May 07 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Executive Chairman | Sell | S | 127.17 | 13,000 | 1,653,210 | 656,755 | 669.8 K to 656.8 K (-1.94 %) |
May 07 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Executive Chairman | Sell | S | 127.84 | 12,000 | 1,534,080 | 644,755 | 656.8 K to 644.8 K (-1.83 %) |
May 07 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Executive Chairman | Sell | S | 127.17 | 13,000 | 1,653,210 | 656,755 | 669.8 K to 656.8 K (-1.94 %) |
Apr 02 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Grant | A | 0.00 | 25,000 | 0 | 669,755 | 644.8 K to 669.8 K (+3.88 %) |
Feb 05 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 124.75 | 5,000 | 623,750 | 649,755 | 654.8 K to 649.8 K (-0.76 %) |
Feb 05 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 123.62 | 5,000 | 618,100 | 654,755 | 659.8 K to 654.8 K (-0.76 %) |
Feb 05 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 126.23 | 11,603 | 1,464,647 | 659,755 | 671.4 K to 659.8 K (-1.73 %) |
Feb 05 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 125.58 | 8,397 | 1,054,495 | 671,358 | 679.8 K to 671.4 K (-1.24 %) |
Jan 16 2018 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Grant | A | 0.00 | 55,819 | 0 | 679,755 | 623.9 K to 679.8 K (+8.95 %) |
Dec 06 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 129.60 | 27,500 | 3,564,000 | 623,936 | 651.4 K to 623.9 K (-4.22 %) |
Dec 04 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 126.91 | 13,000 | 1,649,830 | 651,436 | 664.4 K to 651.4 K (-1.96 %) |
Sep 27 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 118.99 | 25,000 | 2,974,750 | 664,436 | 689.4 K to 664.4 K (-3.63 %) |
Aug 17 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 121.16 | 15,500 | 1,877,980 | 689,436 | 704.9 K to 689.4 K (-2.20 %) |
Aug 07 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 122.03 | 893 | 108,973 | 704,936 | 705.8 K to 704.9 K (-0.13 %) |
Aug 07 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 121.16 | 13,000 | 1,575,080 | 705,829 | 718.8 K to 705.8 K (-1.81 %) |
Jun 29 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 12.45 | 20,000 | 249,000 | 20,000 | |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Option Exercise | A | 13.20 | 21,500 | 283,800 | 21,500 | |
Jun 12 2017 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 5,000 | 0 | 7,000 | 2 K to 7 K (+250.00 %) |
May 12 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 114.77 | 5,000 | 573,850 | 718,829 | 723.8 K to 718.8 K (-0.69 %) |
May 08 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 112.92 | 14,000 | 1,580,880 | 723,829 | 737.8 K to 723.8 K (-1.90 %) |
Mar 21 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 110.37 | 9,500 | 1,048,515 | 707,619 | 717.1 K to 707.6 K (-1.32 %) |
Feb 08 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 113.40 | 1,500 | 170,100 | 717,119 | 718.6 K to 717.1 K (-0.21 %) |
Feb 08 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 112.36 | 5,000 | 561,800 | 718,619 | 723.6 K to 718.6 K (-0.69 %) |
Feb 03 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 108.52 | 13,000 | 1,410,760 | 723,619 | 736.6 K to 723.6 K (-1.76 %) |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 1.50 | 12,500 | 18,750 | 0 | |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 1.50 | 12,500 | 18,750 | 0 | |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 2.74 | 12,500 | 34,250 | 0 | |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 2.74 | 12,500 | 34,250 | 0 | |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 2.84 | 12,500 | 35,500 | 0 | |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 3.26 | 12,500 | 40,750 | 0 | |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 3.26 | 20,000 | 65,200 | 0 | |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 95,000 | 0 | 110,742 | 15.7 K to 110.7 K (+603.48 %) |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Gift | G | 0.00 | 95,000 | 0 | 21,671 | 116.7 K to 21.7 K (-81.43 %) |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 1.50 | 12,500 | 18,750 | 116,671 | 104.2 K to 116.7 K (+12.00 %) |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 1.50 | 12,500 | 18,750 | 104,171 | 91.7 K to 104.2 K (+13.64 %) |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 2.74 | 12,500 | 34,250 | 91,671 | 79.2 K to 91.7 K (+15.79 %) |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 2.74 | 12,500 | 34,250 | 79,171 | 66.7 K to 79.2 K (+18.75 %) |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 2.84 | 12,500 | 35,500 | 66,671 | 54.2 K to 66.7 K (+23.08 %) |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 3.26 | 12,500 | 40,750 | 54,171 | 41.7 K to 54.2 K (+30.00 %) |
Jan 30 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 3.26 | 20,000 | 65,200 | 41,671 | 21.7 K to 41.7 K (+92.29 %) |
Jan 13 2017 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Grant | A | 0.00 | 63,495 | 0 | 736,619 | 673.1 K to 736.6 K (+9.43 %) |
Jan 05 2017 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Option Exercise | A | 15.08 | 5,500 | 82,940 | 5,500 | |
Jan 05 2017 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 2,000 | 0 | 2,000 | 0 to 2 K |
Jan 03 2017 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 994 | 0 | 21,671 | 20.7 K to 21.7 K (+4.81 %) |
Nov 07 2016 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 103.58 | 30,000 | 3,107,400 | 673,124 | 703.1 K to 673.1 K (-4.27 %) |
Oct 04 2016 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 984 | 0 | 20,677 | 19.7 K to 20.7 K (+5.00 %) |
Jul 05 2016 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 386 | 0 | 19,693 | 19.3 K to 19.7 K (+2.00 %) |
Jun 15 2016 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 38.35 | 20,000 | 767,000 | 20,000 | |
May 09 2016 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 94.82 | 10,000 | 948,200 | 703,124 | 713.1 K to 703.1 K (-1.40 %) |
May 09 2016 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 95.38 | 15,000 | 1,430,700 | 713,124 | 728.1 K to 713.1 K (-2.06 %) |
Apr 04 2016 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 386 | 0 | 19,307 | 18.9 K to 19.3 K (+2.04 %) |
Apr 04 2016 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Grant | A | 0.00 | 36,900 | 0 | 728,124 | 691.2 K to 728.1 K (+5.34 %) |
Mar 24 2016 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Grant | A | 0.00 | 82,401 | 0 | 691,224 | 608.8 K to 691.2 K (+13.53 %) |
Mar 24 2016 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | D | 0.00 | 7,947 | 0 | 608,823 | 616.8 K to 608.8 K (-1.29 %) |
Mar 03 2016 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 80.45 | 5,000 | 402,250 | 616,770 | 621.8 K to 616.8 K (-0.80 %) |
Jan 05 2016 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Option Exercise | A | 24.05 | 10,500 | 252,525 | 10,500 | |
Jan 05 2016 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Grant | A | 0.00 | 25,454 | 0 | 621,770 | 596.3 K to 621.8 K (+4.27 %) |
Jan 05 2016 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 53.79 | 199 | 10,704 | 18,921 | 18.7 K to 18.9 K (+1.06 %) |
Dec 21 2015 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 90.91 | 4,000 | 363,640 | 596,316 | 600.3 K to 596.3 K (-0.67 %) |
Dec 15 2015 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 88.80 | 4,000 | 355,200 | 600,316 | 604.3 K to 600.3 K (-0.66 %) |
Dec 08 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 54.80 | 22,700 | 1,243,960 | 1,191,156 | 1.2 M to 1.2 M (-1.87 %) |
Dec 08 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 53.78 | 24,925 | 1,340,467 | 1,213,856 | 1.2 M to 1.2 M (-2.01 %) |
Dec 08 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 52.15 | 15,075 | 786,161 | 1,238,781 | 1.3 M to 1.2 M (-1.20 %) |
Dec 08 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Sell | S | 55.96 | 30,000 | 1,678,800 | 1,253,856 | 1.3 M to 1.3 M (-2.34 %) |
Dec 08 2015 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 90.68 | 5,000 | 453,400 | 604,316 | 609.3 K to 604.3 K (-0.82 %) |
Oct 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 268 | 0 | 18,722 | 18.5 K to 18.7 K (+1.45 %) |
Aug 11 2015 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 92.49 | 5,000 | 462,450 | 609,316 | 614.3 K to 609.3 K (-0.81 %) |
Aug 11 2015 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 92.08 | 5,000 | 460,400 | 614,316 | 619.3 K to 614.3 K (-0.81 %) |
Jul 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 336 | 0 | 18,454 | 18.1 K to 18.5 K (+1.85 %) |
Jul 01 2015 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Grant | A | 0.00 | 75,525 | 0 | 619,316 | 543.8 K to 619.3 K (+13.89 %) |
Jun 22 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | A | 26.58 | 20,000 | 531,600 | 20,000 | |
Jun 15 2015 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 91.17 | 5,000 | 455,850 | 543,791 | 548.8 K to 543.8 K (-0.91 %) |
Jun 15 2015 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 91.30 | 10,000 | 913,000 | 548,791 | 558.8 K to 548.8 K (-1.79 %) |
Apr 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 1.36 | 10,000 | 13,600 | 0 | |
Apr 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Option Exercise | M | 0.96 | 5,000 | 4,800 | 0 | |
Apr 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 1.36 | 10,000 | 13,600 | 18,118 | 8.1 K to 18.1 K (+123.18 %) |
Apr 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Buy | M | 0.96 | 5,000 | 4,800 | 8,118 | 3.1 K to 8.1 K (+160.36 %) |
Apr 02 2015 | ITCI | Intra-Cellular The ... | MARCUS JOEL S | Director | Grant | A | 0.00 | 450 | 0 | 3,118 | 2.7 K to 3.1 K (+16.87 %) |
Mar 20 2015 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 101.37 | 2,500 | 253,425 | 558,791 | 561.3 K to 558.8 K (-0.45 %) |
Mar 20 2015 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 97.84 | 9,800 | 958,848 | 561,291 | 571.1 K to 561.3 K (-1.72 %) |
Mar 11 2015 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Buy | P | 29.99 | 1,500 | 44,985 | 4,000 | 2.5 K to 4 K (+60.00 %) |
Mar 11 2015 | ATRA | Atara Biotherapeut ... | MARCUS JOEL S | Director | Buy | P | 29.32 | 2,500 | 73,300 | 2,500 | 0 to 2.5 K |
Mar 09 2015 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 98.00 | 200 | 19,600 | 571,091 | 571.3 K to 571.1 K (-0.04 %) |
Nov 20 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Option Exercise | M | 20.00 | 5,000 | 100,000 | 67,500 | |
Nov 20 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 56.40 | 2,000 | 112,800 | 216,426 | 218.4 K to 216.4 K (-0.92 %) |
Nov 20 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 56.64 | 500 | 28,320 | 218,426 | 218.9 K to 218.4 K (-0.23 %) |
Nov 20 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 56.65 | 2,500 | 141,625 | 218,926 | 221.4 K to 218.9 K (-1.13 %) |
Nov 20 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Buy | M | 20.00 | 5,000 | 100,000 | 221,426 | 216.4 K to 221.4 K (+2.31 %) |
Nov 17 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Option Exercise | M | 20.00 | 9,800 | 196,000 | 72,500 | |
Nov 17 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 56.48 | 1,900 | 107,312 | 216,426 | 218.3 K to 216.4 K (-0.87 %) |
Nov 17 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 56.58 | 1,900 | 107,502 | 218,326 | 220.2 K to 218.3 K (-0.86 %) |
Nov 17 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 56.50 | 2,500 | 141,250 | 220,226 | 222.7 K to 220.2 K (-1.12 %) |
Nov 17 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 56.49 | 2,500 | 141,225 | 222,726 | 225.2 K to 222.7 K (-1.11 %) |
Nov 17 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 56.57 | 500 | 28,285 | 225,226 | 225.7 K to 225.2 K (-0.22 %) |
Nov 17 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 56.30 | 500 | 28,150 | 225,726 | 226.2 K to 225.7 K (-0.22 %) |
Nov 17 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Buy | M | 20.00 | 9,800 | 196,000 | 226,226 | 216.4 K to 226.2 K (+4.53 %) |
Nov 14 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Option Exercise | M | 20.00 | 200 | 4,000 | 82,300 | |
Nov 14 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 56.51 | 200 | 11,301 | 216,426 | 216.6 K to 216.4 K (-0.09 %) |
Nov 14 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Buy | M | 20.00 | 200 | 4,000 | 216,626 | 216.4 K to 216.6 K (+0.09 %) |
Nov 12 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Option Exercise | M | 20.00 | 2,500 | 50,000 | 82,500 | |
Nov 12 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Buy | M | 20.00 | 2,500 | 50,000 | 216,426 | 213.9 K to 216.4 K (+1.17 %) |
Sep 19 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Grant | A | 46.90 | 5,000 | 234,500 | 213,926 | 208.9 K to 213.9 K (+2.39 %) |
Aug 21 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Option Exercise | M | 20.00 | 5,000 | 100,000 | 85,000 | |
Aug 21 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Option Exercise | M | 20.00 | 10,000 | 200,000 | 90,000 | |
Aug 21 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 46.60 | 2,500 | 116,500 | 208,926 | 211.4 K to 208.9 K (-1.18 %) |
Aug 21 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 46.60 | 2,500 | 116,500 | 211,426 | 213.9 K to 211.4 K (-1.17 %) |
Aug 21 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Buy | M | 20.00 | 5,000 | 100,000 | 213,926 | 208.9 K to 213.9 K (+2.39 %) |
Aug 21 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 46.70 | 2,500 | 116,750 | 208,926 | 211.4 K to 208.9 K (-1.18 %) |
Aug 21 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 46.57 | 2,500 | 116,425 | 211,426 | 213.9 K to 211.4 K (-1.17 %) |
Aug 21 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Sell | S | 46.60 | 5,000 | 233,000 | 213,926 | 218.9 K to 213.9 K (-2.28 %) |
Aug 21 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Buy | M | 20.00 | 10,000 | 200,000 | 218,926 | 208.9 K to 218.9 K (+4.79 %) |
Aug 11 2003 | ARE | ALEXANDRIA REAL ES ... | MARCUS JOEL S | Chief Executive Off ... | Grant | A | 45.10 | 25,000 | 1,127,500 | 208,926 | 183.9 K to 208.9 K (+13.59 %) |